Intox

Intox, an Aragen Life Sciences company, is a prominent non-clinical and clinical safety assessment service provider based in Pune, India. With nearly 30 years of experience, the company provides a wide range of GLP-compliant services, including toxicology, bioanalysis, safety pharmacology, and genetic toxicology. Operating from a state-of-the-art, AAALAC-accredited campus, Intox utilizes advanced laboratory equipment and a team of board-certified toxicologists, pathologists, and veterinarians to conduct comprehensive safety studies. The company is integrated into the broader Aragen portfolio, which offers end-to-end discovery and development solutions. Its laboratory facilities are designed to support regulatory requirements across diverse sectors, including pharmaceuticals, biotechnology, vaccines, crop protection, and industrial chemicals.

The organization serves as a critical partner for developers navigating the complex landscape of global regulatory registrations, providing high-quality data that adheres to international guidelines set by agencies such as the US-FDA, EMA, and OECD. By delivering rigorous in vivo and in vitro testing, Intox assists clients in streamlining the development lifecycle of molecules from initial design to final registration. Their long-standing track record includes thousands of successful GLP studies, supporting vaccine manufacturers and chemical developers in achieving safe and compliant product outcomes. Through specialized services like chronic toxicity, reproductive toxicology, and inhalation studies, the company addresses specific safety challenges that are essential for successful market entry and product innovation.